Crossmark Global Holdings’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-9,350
| Closed | -$392K | – | 1451 |
|
2021
Q3 | $392K | Buy |
9,350
+80
| +0.9% | +$3.35K | 0.01% | 1046 |
|
2021
Q2 | $360K | Buy |
9,270
+20
| +0.2% | +$777 | 0.01% | 1085 |
|
2021
Q1 | $316K | Buy |
9,250
+360
| +4% | +$12.3K | 0.01% | 1140 |
|
2020
Q4 | $403K | Buy |
+8,890
| New | +$403K | 0.01% | 944 |
|
2019
Q3 | – | Sell |
-4,870
| Closed | -$250K | – | 1370 |
|
2019
Q2 | $250K | Sell |
4,870
-360
| -7% | -$18.5K | 0.01% | 1179 |
|
2019
Q1 | $300K | Buy |
5,230
+120
| +2% | +$6.88K | 0.01% | 1117 |
|
2018
Q4 | $214K | Buy |
5,110
+2,300
| +82% | +$96.3K | 0.01% | 1258 |
|
2018
Q3 | $212K | Buy |
+2,810
| New | +$212K | 0.01% | 1518 |
|